A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

Detalles Bibliográficos
Autores principales: Spagnuolo, Vincenzo, Galli, Laura, Poli, Andrea, Bigoloni, Alba, Fumagalli, Luca, Gianotti, Nicola, Nozza, Silvia, Ferrari, Davide, Locatelli, Massimo, Lazzarin, Adriano, Castagna, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352870/
https://www.ncbi.nlm.nih.gov/pubmed/30774311
http://dx.doi.org/10.2147/DDDT.S192124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352870/
https://www.ncbi.nlm.nih.gov/pubmed/30774311
http://dx.doi.org/10.2147/DDDT.S192124

Ejemplares similares